advanced – pharma.markets

FDA approves ripretinib for advanced gastrointestinal stromal tumor

17/05/2020 MaP 0

On May 15, 2020, the Food and Drug Administration approved ripretinib (QINLOCK, Deciphera Pharmaceuticals, LLC.), for adult patients with advanced gastrointestinal stromal tumor (GIST) who […]

Williams Advanced Engineering proud to be part of the Ventilator Challenge

02/04/2020 MaP 0

Williams Advanced Engineering (WAE) is proud to be playing a significant role in a consortium of UK industrial, technology and engineering businesses from across the […]